EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Eupraxia Pharmaceuticals (EPRX) Stock: Buy, Sell, or Hold?
$8.09
+0.46 (+5.96%)
▲
5d:
+19.6%
30d:
+21.03%
90d:
+21.21%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (51%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$6.76 – $7.63
Position: EXTENDED
Forward P/E & Valuation
-7.4x
Next 12M consensus est.
Wall Street Target
$16.61
+117.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.30 / $8.49
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: EPRX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When EPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: EPRX is currently trading at $8.09, which is considered extended relative to its 30-day fair value range of $6.76 to $7.63.
Technical Outlook: Technically, EPRX is in a uptrend. Immediate support is located at $6.30, while resistance sits at $8.49. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $16.61 (+117.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EPRX is in a uptrend. Immediate support is located at $6.30, while resistance sits at $8.49. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $16.61 (+117.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.76 -
$7.63
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
51.1%
Trading Range & Key Levels
30-Day Trading Range
$6.76 -
$7.63
Current vs Trading Range
EXTENDED
Support Level
$6.30
Resistance Level
$8.49
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+6.0% above its trading range)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 117.7% below Wall St target ($16.61)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-7.36
Wall Street Target
$16.61
(+117.7%)
Share EPRX Analysis
Share this live EPRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EPRX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $EPRX is growing as the company reaches its 120-patient target and presents encouraging early durability data. Investors await further developments in November.
Key Retail Themes:
Company progress towards targets
Encouraging early data
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:29 PM ET
Data refreshes hourly during market hours. Next update: 3:29 PM
Data refreshes hourly during market hours. Next update: 3:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EPRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EPRX Research Pages
